Licensed pharmacological options for weight management in the UK include: Semaglutide (Wegovy, 2.4 mg weekly) a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity
[12] [13] Review your meal compositionmeals lacking sufficient protein, healthy fats, or fibre may not provide lasting fullness despite Ozempic's effects
, BPC 157
Jung SY,Eberlin LS,Johnson JR,Kittles RA,Ballester LY,Parsawar K,Siddiqui MM,Gao J,Langer Gramer A,Bollag RJ,Terris MK,Lotan Y,Creighton CJ,Lerner SP,Sreekumar A,Kaipparettu BA,Putluri N
The non-hormonal mechanism makes them safe to use alongside hormone therapy if desired